An extensive study of propelling opportunities in, “Opioid Use Disorder (OUD) Market Size, Share & Trends Analysis Report by Product Type (Neurovascular Stents, Embolic Coils, Neurothrombectomy Devices, Access Devices, Embolic Protection Devices, Neurovascular Balloon Catheters, Others), Procedure Type, Technology, Material Type, Indication/Disease Type, Patient Demographics, Deployment Method, Treatment Approach, End-users, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” A comprehensive report of growing market landscapes in the opioid use disorder (OUD) sector uncovering key growth drivers including niche market leadership, technology-enabled distribution, and increasing consumer needs supporting opioid use disorder (OUD) potential to scale globally.
Global Opioid Use Disorder (OUD) Market Forecast 2035:
According to the report, the opioid use disorder (OUD) market is anticipated to grow from USD 4.2 Billion in 2025 to USD 11.8 Billion in 2035 at a CAGR of 10.9% during the forecast. The opioid use disorder (OUD) market is growing rapidly due to increased incidences of opioid addiction worldwide and increasing funding for integrated care models. Innovations are happening in telemedicine and remote monitoring in North America and Europe due to work being done by private companies and technology vendors. There are also VR-based clinician training programs made available to improve workforce capacities and increase treatment delivery.
Additionally, AI-powered platforms are being utilized for treatment plans, operationalized as scalable care solutions that offer personalized treatment options as the demand grows in developed and emerging markets. Trend transitions to Client-based care, called in-home care management, is also a catalyst for the growth of this market, as well as with the COVID-19 pandemic and recent changes in healthcare policies for remote care. There is significant investment in cybersecurity for connected treatment devices to keep data secure for sensitive patient information.
“Key Driver, Restraint, and Growth Opportunity Defining the Global Opioid Use Disorder (OUD) Market”
The global market for opioid use disorder (OUD) is on the rise due to the increasing rates of opioid addiction and demand for more accessible and patient-centered treatment options. Advances in telemedicine, digital health platforms, and AI-enabled digital monitoring are increasing the personalization of care and the possibility of continuous care and monitoring from the comfort of the patient’s home, which will also continue to encourage growth in the market. Increased awareness campaigns and government-level initiatives are also leading to increasing diagnosis of opioid use disorder and uptake of OUD treatment globally.
In spite of this growth trajectory, challenges still remain such as poor insurance reimbursement, shortages in the addiction treatment workforce, regulatory issues, limitations with safety-monitoring and care coordination, stigma, and fragmented health care systems meaning patients cannot access high-quality care.
Nevertheless, opportunities also exist at the intersection of developing digital health innovations and the demand for patient-centered therapies for use in or around their homes. Investment in infrastructure around health care services, technology-based care models, and more collaborative care across sectors will help to sustain growth and create new opportunities in the OUD market.
"Impact of Global Tariff Policies on the Global Opioid Use Disorder (OUD) Market Growth and Strategy"
International tariffs create a negative impact on the OUD market by increasing the price of critical medication, digital health devices, and treatment technology used in OUD. Tariffs on pharmaceuticals, or remote monitoring equipment, coming from places like China or Mexico will increase the price of medications and supplies, and may limit patients' access to necessary treatments for their OUD.
Owing to which the supply chain issues, manufacturers are increasing the diversification of their sourcing of supplies as a way to reduce dependence on a foreign supplier, and they are investing in U.S. production capabilities. Manufacturers are also adopting more innovative technologies and utilizing more efficient processes to continue controlling costs. Policymakers will need to consider the implications of tariff policy on affordability and accessibility of OUD treatments to provide equitable care for patients.
Expansion of Global Opioid Use Disorder (OUD) Market
“Rising Addiction Rates, Digital Health Innovations, and Expanding Telemedicine Drive Opioid Use Disorder (OUD) Market Expansion”
Regional Analysis of Global Opioid Use Disorder (OUD) Market
Key players in the global opioid use disorder (OUD) market include prominent companies such as AbbVie Inc., Alkermes PLC, Amneal Pharmaceuticals, Aurobindo Pharma, BioDelivery Sciences International, Braeburn Pharmaceuticals (Camurus AB), Cipla Limited, Dr. Reddy's Laboratories, Hikma Pharmaceuticals, Indivior PLC, Johnson & Johnson, Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals, Mylan N.V. (Viatris), Orexo AB, Par Pharmaceutical (Endo International), Pfizer Inc., Purdue Pharma, Rhodes Pharmaceuticals, Sandoz (Novartis), Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Titan Pharmaceuticals, Zydus Cadila (Cadila Healthcare), along with several other key players.
The global opioid use disorder (OUD) market has been segmented as follows:
Global Opioid Use Disorder (OUD) Market Analysis, by Treatment Type
Global Opioid Use Disorder (OUD) Market Analysis, by Drug Formulation
Global Opioid Use Disorder (OUD) Market Analysis, by Route of Administration
Global Opioid Use Disorder (OUD) Market Analysis, by Distribution Channel
Global Opioid Use Disorder (OUD) Market Analysis, by Treatment Setting
Global Opioid Use Disorder (OUD) Market Analysis, by Patient Demographics
Global Opioid Use Disorder (OUD) Market Analysis, by Disease Severity
Global Opioid Use Disorder (OUD) Market Analysis, by Therapy Duration
Global Opioid Use Disorder (OUD) Market Analysis, by End-Users
Global Opioid Use Disorder (OUD) Market Analysis, by Region
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact US
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation